PPAR alpha slective compounds for the treatment of dyslipidemia and other lipid disorders

Details for Australian Patent Application No. 2003256842 (hide)

International Classifications

Event Publications

6 November 2003 Complete Application Filed

Priority application(s): 60/399,520 30.07.02 US

25 March 2004 Application Open to Public Inspection

Published as AU-B-2003256842

19 February 2009 Application Accepted

Published as AU-B-2003256842

18 June 2009 Standard Patent Sealed

18 June 2009 Corrigenda

Applications Accepted - Name Index Under the name Merck & Co., Inc., Application No. 2003256842, under INID(54) correct the title to read PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders

21 January 2010 Amendment Made

The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.